Skip to main content
SpringerLink
Log in

Association of apolipoprotein J-positive β-amyloid plaques with dystrophic neurites in alzheimer’s disease brain

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Apolipoprotein J (apoJ), also known as clusterin and SP-40,40, binds soluble beta-amyloid (Aβ and is up-regulated in the Alzheimer’s disease (AD) brain. In the present study we classified apoJ-immunopositive Aβ deposits in AD temporal cortex, and found apoJ-immunoreactive plaques were often associated with dystrophic neurites. Quantitative immunohistochemical analysis of five AD brains showed that 29% of Aβ deposited in the parenchyma was associated with apoJ. Of Aβ deposits with apoJ immunopositivity, 71% were associated with phospho-tau-positive dystrophic neurites in the surrounding tissue. Conversely, 64% of phospho-tau-labeled neuritic deposits were labeled with apoJ. ApoJ was found at the core of these deposits, and co-localized with the amyloid staining agent thioflavine-S. To test the direct effects of apoJ on tau metabolism, we treated cells in culture with apoJ-containing conditioned media, and we injected apoJ-containing media into the rat hippocampus. Using both systems, we observed increases in levels of tau and phosphorylated tau. Our findings demonstrate that apoJ immunopositivity strongly correlates with the presence of amyloid and associated neuritic dystrophy in the neuropil of AD temporal cortex, and supports a model where extracellular apoJ facilitates the conversion of diffuse Aβ deposits into amyloid and enhances tau phosphorylation in neurites surrounding these plaques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alonzo NC, BT Hyman, GW Rebeck and SM Greenberg (1999) Progression of cerebral amyloid angiopathy: accumulation of amyloid-ß40 in affected vessels.J. Neuropathol. Exp. Neurol. 57, 353–359.

    Article  Google Scholar 

  • Augustinack JC, A Schneider, EM Mandelkow and BT Hyman (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease.Acta Neuropathol. 103, 26–35.

    Article  PubMed  CAS  Google Scholar 

  • Bales KR, T Verina, DJ Cummins, Y Du, RC Dodel, J Saura, CE Fishman, CA DeLong, P Piccardo, V Petegnief, B Ghetti and SM Paul (1999) Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer’s disease.Proc. Natl. Acad. Sci. USA 96, 15233–15238.

    Article  PubMed  CAS  Google Scholar 

  • Boggs LN, KS Fuson, M Baez, L Churgay, D McClure, G Becker and PC May (1996) Clusterin (Apo J) protects againstin vitro amyloid-beta(1-40) neurotoxicity.J. Neurochem. 67, 1324–1327.

    PubMed  CAS  Google Scholar 

  • Burns MP, WJ Noble, V Olm, K Gaynor, E Casey, J LaFrancois, L Wang and K Duff (2003) Co-localization of cholesterol, apolipoprotein E and fibrillar Aß in amyloid plaques.Mol. Brain Res. 110, 119–125.

    Article  PubMed  CAS  Google Scholar 

  • Cho HS, BT Hyman, SM Greenberg and GW Rebeck (2001), Quantification of apoE domains in Alzheimer disease brain suggests a role for apoE in Aß aggregation.J. Neuropathol. Exp. Neurol. 60, 342–349.

    PubMed  CAS  Google Scholar 

  • Choi-Miura NH, Y Ihara, K Fukuchi, M Takeda, Y Nakano, T Tobe and M Tomita (1992), SP-40,40 is a constituent of Alzheimer’s amyloid.Acta Neuropathol. 83, 260–264.

    Article  PubMed  CAS  Google Scholar 

  • Cruz L, B Urbanc, SV Buldyrev, R Christie, T Gómez-Isla, S Havlin, M McNamara, HE Stanley and BT Hyman (1997) Aggregation and disaggregation of senile plaques in Alzheimer disease.Proc. Natl. Acad. Sci. USA 94, 7612–7616.

    Article  PubMed  CAS  Google Scholar 

  • Cummings BJ, CJ Pike, R Shankle and CW Cotman (1996) Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease.Neurobiol. Aging 17, 921–933.

    Article  PubMed  CAS  Google Scholar 

  • DeMattos RB, MA O’Dell, M Parsadanian, JW Taylor, JAK Harmony, KR Bales, SM Paul, BJ Aronow and DM Holtzman (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model for Alzheimer’s disease.Proc. Natl. Acad. Sci. USA 99, 10843–10848.

    Article  PubMed  CAS  Google Scholar 

  • Dickson DW, HA Crystal, C Bevona, W Honer, I Vincent and P Davies (1995) Correlations of synaptic and pathological markers with cognition of the elderly.Neurobiol. Aging 16, 285–304.

    Article  PubMed  CAS  Google Scholar 

  • Ghiso J, E Matsubara, A Koudinov, NH Choi-Miura, M Tomita, T Wisniewski and B Frangione (1993) The cerebrospinal fluid soluble form of Alzheimer’s amyloid beta is complexed to SP40,40 (apolipoprotein J), an inhibitor of the complement membrane attack complex.Biochem. J. 293, 27–30.

    PubMed  CAS  Google Scholar 

  • Giannakopoulos P, E Kovari E, LE French, I Viard, PR Hof and C Bouras (1998) Possible neuroprotective role of clusterin in Alzheimer disease: a quantitative immunocytochemical study.Acta Neuropathol. 95, 387–394.

    Article  PubMed  CAS  Google Scholar 

  • Gómez-Isla T, HL West, GW Rebeck, SD Harr, JH Growdon, JJ Locascio, TT Perls, LA Lipsitz and BT Hyman (1996) Clinical and pathological correlates of apolipoprotein E epsilon-4 in Alzheimer’s disease.Ann. Neurol. 39, 62–70.

    Article  PubMed  Google Scholar 

  • Hammad SM, S Ranganathan, E Loukinova, WO Twal and WS Argraves (1997) Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.J. Biol. Chem. 272, 18644–18649.

    Article  PubMed  CAS  Google Scholar 

  • Han BH, RB DeMattos, LL Dugan, JS Kim-Han, RP Brendza, JD Fryer, M Kierson, J Cirrito, K Quick, JAK Harmony, BJ Aronow and DM Holtzman (2001) Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia.Nat. Med. 7, 338–343.

    Article  PubMed  CAS  Google Scholar 

  • Hardy J (1997) The Alzheimer family of diseases: many etiologies, one pathogenesis?Proc. Natl. Acad. Sci. USA 94, 2095–2097.

    Article  PubMed  CAS  Google Scholar 

  • Harr SD, L Uint, R Hollister, BT Hyman and AJ Mendez (1996) Brain expression of apolipoproteins E, J, and A-I in Alzheimer’s disease.J. Neurochem. 66, 2429–2435.

    Article  PubMed  CAS  Google Scholar 

  • Holtzman DM, KR Bales, T Tenkova, AM Fagan, M Parsadanian, LJ Sartorius, B Mackey, J Olney, D McKeel, D Wozniak and SM Paul (2000a) Apolipoprotein E isoform-dependant amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease.Proc. Natl. Acad. Sci. USA 97, 2892–2897.

    Article  PubMed  CAS  Google Scholar 

  • Holtzman DM, AM Fagan, B Mackey, T Tenkova, L Sartorius, SM Paul, K Bales, KH Ashe, MC Irizarry and BT Hyman (2000b) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model.Ann. Neurol. 47, 739–747.

    Article  PubMed  CAS  Google Scholar 

  • Irizarry MC, BS Cheung, GW Rebeck, SM Paul, KR Bales and BT Hyman (2000), Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid ß-peptide deposition in homozygous APPV717F transgenic mice.Acta Neuropathol. 100, 451–458.

    Article  PubMed  CAS  Google Scholar 

  • Kida E, NH Choi-Miura and KE Wisniewski (1995) Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer’s disease and Down’s syndrome brain.Brain Res. 685, 211–216.

    Article  PubMed  CAS  Google Scholar 

  • Kindy MS and DJ Rader (1998) Reduction in amyloid A formation in apolipoprotein-E-deficient mice.Am. J. Pathol. 152, 1387–1395.

    PubMed  CAS  Google Scholar 

  • Matsubara E, B Frangione and J Ghiso (1995) Characterization of apolipoprotein J-Alzheimer’s amyloid-beta interaction.J. Biol. Chem. 270, 7563–7567.

    Article  PubMed  CAS  Google Scholar 

  • Matsubara E, C Soto, S Governale, B Frangione and J Ghiso (1996) Apolipoprotein J and Alzheimer’s amyloid beta solubility.Biochem. J. 316, 671–679.

    PubMed  CAS  Google Scholar 

  • McGeer PL, T Kawamata and DG Walker (1992) Distribution of clusterin in Alzheimer brain tissue.Brain Res. 579, (1992) 337–341.

    Article  PubMed  CAS  Google Scholar 

  • Nakai M, T Kawamata, T Taniguchi, K Maeda and C Tanaka (1996) Expression of apolipoprotein E mRNA in rat microglia.Neurosci. Lett. 211, 41–44.

    Article  PubMed  CAS  Google Scholar 

  • Namba Y, M Tomonaga, H Kawasaki, E Otomo and K Ikeda (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeld-Jakob disease.Brain Res. 541, 163–166.

    Article  PubMed  CAS  Google Scholar 

  • Nishida K, AJ Quantock, A Dota, NH Choi-Miura and S Kinoshita (1999) Apolipoproteins J and E co-localise with amyloid with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.Br. J. Ophthalmol. 83, 1178–1182.

    Article  PubMed  CAS  Google Scholar 

  • Paxinos G and C Watson (1997)The Rat Brain in Stereotaxic Coordinates (Academic Press: New York).

    Google Scholar 

  • Pitas RE, JK Boyles, SH Lee, D Foss and RW Mahley (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.Biochem. Biophys. Acta 917, 148–161.

    PubMed  CAS  Google Scholar 

  • Qiu Z, Strickland DK, Hyman BT, and GW Rebeck (2002) ?2-Macroglobulin exposure reduces calcium responses toN-methyl-D-aspartate via low density lipoprotein recepor-related protein in cultured hippocampal neurons.J. Biol. Chem. 277, 14459–14466.

    Google Scholar 

  • Sasaki K, K Doh-ura, Y Wakisaka and T Iwaki (2002) Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with ?-synucle-inopathies.Acta Neuropathol. 104, 225–230.

    Article  PubMed  CAS  Google Scholar 

  • Scheuner D, C Eckman, M Jensen, X Song, M Citron, N Suzuki, TD Bird, J Hardy, M Hutton, W Kukull, E Larson, E Levy-Lahad, M Viitanen, E Peskind, P Poorkaj, G Schellenberg, R Tanzi, W Wasco, L Lannfelt, D Selkoe and S Younkin (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increasedin vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease.Nat. Med. 2, 850–852.

    Article  Google Scholar 

  • Schnell SA, WA Staines and MW Wessendorf (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue.J. Histochem. Cytochem. 47, 719–730.

    PubMed  CAS  Google Scholar 

  • Selkoe DJ (1998) The cell biology of ß-amyloid precursor protein and presenilin in Alzheimer’s disease.Trends Cell Biol. 8, 447–453.

    Article  PubMed  CAS  Google Scholar 

  • Stoltzner SE, TJ Grenfell, C Mori, KE Wisniewski, TM Wisniewski, DJ Selkoe and CA Lemere (2002) Temporal accrual of complement proteins in amyloid plaques in Down’s syndrome with Alzheimer’s disease.Am. J. Pathol. 156, 489–499.

    Google Scholar 

  • Thal DR, U Rüb, C Schultz, I Sassin, E Ghebremedhin, K Del Tredici, E Braak and H Braak (2000) Sequence of Aß-protein deposition in the human medial temporal lobe.J. Neuropathol. Exp. Neurol. 59, 733–748.

    PubMed  CAS  Google Scholar 

  • Wisniewski T and B Frangione (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.Neurosci. Lett. 135, 235–238.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Alzheimer Research Unit, Massachusetts General Hospital, 02129, Charlestown, MA, USA

    Matthew D. Martin-Rehrmann

  2. Department of Neuroscience, Georgetown University Medical Center, 20007, Washington, DC, USA

    Hyang-Sook Hoe & G. William Rebeck

  3. Graduate School of Neural and Behavioural Sciences, International Max Planck Research School, University of Tuebingen, Tuebingen, Germany

    Eleonora M. Capuani

Authors
  1. Matthew D. Martin-Rehrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyang-Sook Hoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eleonora M. Capuani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. William Rebeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. William Rebeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martin-Rehrmann, M.D., Hoe, HS., Capuani, E.M. et al. Association of apolipoprotein J-positive β-amyloid plaques with dystrophic neurites in alzheimer’s disease brain. neurotox res 7, 231–241 (2005). https://doi.org/10.1007/BF03036452

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03036452

Keywords

Search

Navigation